186 related articles for article (PubMed ID: 31572130)
1. Proliferation of Inhibitory Input to the Substantia Nigra in Experimental Parkinsonism.
Faynveitz A; Lavian H; Jacob A; Korngreen A
Front Cell Neurosci; 2019; 13():417. PubMed ID: 31572130
[TBL] [Abstract][Full Text] [Related]
2. NMDA receptors are altered in the substantia nigra pars reticulata and their blockade ameliorates motor deficits in experimental parkinsonism.
Sitzia G; Mantas I; Zhang X; Svenningsson P; Chergui K
Neuropharmacology; 2020 Sep; 174():108136. PubMed ID: 32474027
[TBL] [Abstract][Full Text] [Related]
3. GABAergic control of rat substantia nigra dopaminergic neurons: role of globus pallidus and substantia nigra pars reticulata.
Celada P; Paladini CA; Tepper JM
Neuroscience; 1999 Mar; 89(3):813-25. PubMed ID: 10199615
[TBL] [Abstract][Full Text] [Related]
4. Effects of noradrenaline and serotonin depletions on the neuronal activity of globus pallidus and substantia nigra pars reticulata in experimental parkinsonism.
Delaville C; Navailles S; Benazzouz A
Neuroscience; 2012 Jan; 202():424-33. PubMed ID: 22138505
[TBL] [Abstract][Full Text] [Related]
5. GABAergic control of substantia nigra dopaminergic neurons.
Tepper JM; Lee CR
Prog Brain Res; 2007; 160():189-208. PubMed ID: 17499115
[TBL] [Abstract][Full Text] [Related]
6. Enhanced visual responses in the superior colliculus and subthalamic nucleus in an animal model of Parkinson's disease.
Rolland M; Carcenac C; Overton PG; Savasta M; Coizet V
Neuroscience; 2013 Nov; 252():277-88. PubMed ID: 23916713
[TBL] [Abstract][Full Text] [Related]
7. Acute dopamine receptor blockade in substantia nigra pars reticulata: a possible model for drug-induced Parkinsonism.
Cáceres-Chávez VA; Hernández-Martínez R; Pérez-Ortega J; Herrera-Valdez MA; Aceves JJ; Galarraga E; Bargas J
J Neurophysiol; 2018 Dec; 120(6):2922-2938. PubMed ID: 30256736
[TBL] [Abstract][Full Text] [Related]
8. Neuronal inhibition and synaptic plasticity of basal ganglia neurons in Parkinson's disease.
Milosevic L; Kalia SK; Hodaie M; Lozano AM; Fasano A; Popovic MR; Hutchison WD
Brain; 2018 Jan; 141(1):177-190. PubMed ID: 29236966
[TBL] [Abstract][Full Text] [Related]
9. Transmission of delta band (0.5-4 Hz) oscillations from the globus pallidus to the substantia nigra pars reticulata in dopamine depletion.
Whalen TC; Parker JE; Gittis AH; Rubin JE
J Comput Neurosci; 2022 Aug; 51(3):361-380. PubMed ID: 37266768
[TBL] [Abstract][Full Text] [Related]
10. Intrapallidal administration of 6-hydroxydopamine mimics in large part the electrophysiological and behavioral consequences of major dopamine depletion in the rat.
Abedi PM; Delaville C; De Deurwaerdère P; Benjelloun W; Benazzouz A
Neuroscience; 2013 Apr; 236():289-97. PubMed ID: 23376117
[TBL] [Abstract][Full Text] [Related]
11. Levodopa enhances synaptic plasticity in the substantia nigra pars reticulata of Parkinson's disease patients.
Prescott IA; Dostrovsky JO; Moro E; Hodaie M; Lozano AM; Hutchison WD
Brain; 2009 Feb; 132(Pt 2):309-18. PubMed ID: 19050033
[TBL] [Abstract][Full Text] [Related]
12. Subthalamic stimulation-induced synaptic responses in substantia nigra pars compacta dopaminergic neurons in vitro.
Iribe Y; Moore K; Pang KC; Tepper JM
J Neurophysiol; 1999 Aug; 82(2):925-33. PubMed ID: 10444687
[TBL] [Abstract][Full Text] [Related]
13. Using a novel PV-Cre rat model to characterize pallidonigral cells and their terminations.
Oh YM; Karube F; Takahashi S; Kobayashi K; Takada M; Uchigashima M; Watanabe M; Nishizawa K; Kobayashi K; Fujiyama F
Brain Struct Funct; 2017 Jul; 222(5):2359-2378. PubMed ID: 27995326
[TBL] [Abstract][Full Text] [Related]
14. Acute nigro-striatal blockade alters cortico-striatal encoding: an in vivo electrophysiological study.
Prosperetti C; Di Giovanni G; Stefani A; Möller JC; Galati S
Exp Neurol; 2013 Sep; 247():730-6. PubMed ID: 23537952
[TBL] [Abstract][Full Text] [Related]
15. Microglia may compensate for dopaminergic neuron loss in experimental Parkinsonism through selective elimination of glutamatergic synapses from the subthalamic nucleus.
Aono H; Choudhury ME; Higaki H; Miyanishi K; Kigami Y; Fujita K; Akiyama JI; Takahashi H; Yano H; Kubo M; Nishikawa N; Nomoto M; Tanaka J
Glia; 2017 Nov; 65(11):1833-1847. PubMed ID: 28836295
[TBL] [Abstract][Full Text] [Related]
16. Substantia nigra control of basal ganglia nuclei.
Guatteo E; Cucchiaroni ML; Mercuri NB
J Neural Transm Suppl; 2009; (73):91-101. PubMed ID: 20411770
[TBL] [Abstract][Full Text] [Related]
17. Striatal, pallidal, and pars reticulata evoked inhibition of nigrostriatal dopaminergic neurons is mediated by GABA(A) receptors in vivo.
Paladini CA; Celada P; Tepper JM
Neuroscience; 1999 Mar; 89(3):799-812. PubMed ID: 10199614
[TBL] [Abstract][Full Text] [Related]
18. Striatal Direct and Indirect Pathway Output Structures Are Differentially Altered in Mouse Models of Huntington's Disease.
Barry J; Akopian G; Cepeda C; Levine MS
J Neurosci; 2018 May; 38(20):4678-4694. PubMed ID: 29691329
[TBL] [Abstract][Full Text] [Related]
19. Substantia Nigra Pars Reticulata Projections to the Pedunculopontine Nucleus Modulate Dyskinesia.
Hu Y; Ma TC; Alberico SL; Ding Y; Jin L; Kang UJ
Mov Disord; 2023 Oct; 38(10):1850-1860. PubMed ID: 37461292
[TBL] [Abstract][Full Text] [Related]
20. Activation of metabotropic glutamate receptor 1 inhibits glutamatergic transmission in the substantia nigra pars reticulata.
Wittmann M; Hubert GW; Smith Y; Conn PJ
Neuroscience; 2001; 105(4):881-9. PubMed ID: 11530226
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
